17/03/2026
With recent concerns surrounding meningitis, we feel it is important to share clear, clinically grounded information on both the condition and the role that HYPO21 can play in supporting hygiene protocols.
Meningitis is most commonly caused by bacterial pathogens including Streptococcus pneumoniae and Neisseria meningitidis. These organisms can colonise the respiratory tract and oral cavity before progressing, making effective surface and mucosal hygiene critically important in reducing transmission risk.
Pure hypochlorous acid has been extensively documented for its rapid antimicrobial activity. It works by mimicking the body’s own immune response, disrupting the cell walls of pathogens and leading to their swift inactivation. Importantly, specific evidence confirms that HOCl is highly effective against key meningitis causing bacteria, including Streptococcus pneumoniae and Neisseria meningitidis.
What differentiates HYPO21 is the purity and stability of its formulation. Unlike generic HOCl products, HYPO21 is produced using advanced filtration and controlled manufacturing processes that ensure a consistent, highly bioavailable solution. This allows for maximum antimicrobial efficacy without compromising tissue compatibility.
In practice, the combined use of HYPO21 Skin Spray and HYPO21 Oral Rinse provides a comprehensive approach. The Skin Spray supports external decontamination and barrier protection, while the Oral Rinse targets the oral cavity where many pathogens reside and proliferate. Together, they create a synergistic defence that aligns closely with how the body naturally protects itself.
In a time where infection control is under increased scrutiny, the use of a clinically aligned, pure HOCl solution such as HYPO21 offers both reassurance and measurable effectiveness.
We have both in stock. DM me or order online (link in bio)
